These 4 Marijuana Stocks Are Raising Eyebrows

CORAL GABLES, FL/ ACCESSWIRE / December 26, 2018 / While all other sectors of the market are concerned with high volatility, the cannabis industry has enjoyed positive gains as a result of recent legislation passed that will allow producers to ramp up production to meet the needs of consumers in the space. With this new market, we've seen the amount of public support for cannabis soar well over 60%, subsequently driving an increasing amount of investments into the budding market. Premier Health Group (PHGRF) (PHGI), MariMed Inc (MRMD), New Age Beverages Corp (NBEV), and CV Sciences, Inc (CVSI) are 4 pot stocks to pay attention to as we approach the new year.

Premier Health Group (PHGRF) (PHGI) saw its company shares enjoy a 2.87% boost in midday trading on Wednesday afternoon, trading at $0.64 per share, up from $0.53 at the end of October and $0.59 on December 9. The Company has been working tirelessly to develop innovative healthcare approaches that combine human skill-based expertise with innovative new technologies in the healthcare sector. Currently, Premier supports a consistently growing active patient network of over 100,000 individuals who take advantage of the company's subsidiary, HealthVue.

Premier Health Group (PHGRF) (PHGI) announced, towards the end of November, that it had began discussing potential opportunities with licensed cannabis procurers under the Access to Cannabis for Medical Purposes Regulation (ACMPR), as well as Canadian government officials, in an attempt to lay down a framework to eventually begin treating their patients with medicinal cannabis.

''With over 110,000 active patients in our clinic ecosystem, it is important that we provide them with the best possible information that allows them to make informed decisions about their personal and family's health. Providing our family physicians with the appropriate tools and knowledge to prescribe cannabis or with the ability to refer patients to a specialist within our clinics is a key outcome of this initiative," said Dr. Essam Hamza, CEO of Premier Health.

For More Information On Premier Health Group, Click Here

MariMed Inc (MRMD), the multi-state cannabis operator and hemp development and distribution company, saw company shares enjoy impressive gains in midday trading on Wednesday, as shares jumped 16.33% to $2.85 per share. The Company's recent success may be connected to the passing of the US Farm Bill which, in its language, allows for the legalization of industrial hemp.

In an official press release, the Company's executive leadership shared their thoughts: "Legal hemp has the potential to reshape America's health and wellness landscape," said Charles Finnie, MariMed's Chief Strategy Officer. "CBD will likely become a separate industry from the highly regulated, state-legal cannabis industry that remains illegal at the federal level. Lifting federal restrictions on hemp cultivation, research and distribution will enable advanced medical research, as well as increased agricultural production of pharmaceutical-quality CBD products that avoid the side effects and addiction risks of some pharmaceuticals ."

For More Information on MariMed, Inc, Click Here

New Age Beverages (NBEV) along with other cannabis stocks, saw its shares climb early Wednesday afternoon to $5.19 per share, up 9.75%. On Christmas eve, the Company announced the closing of the merger with Morinda Holdings, Inc, a Utah-based healthy beverages and lifestyles company with operations in more than 60 countries around the world.

According to the official press release, the merger will create one of the largest healthy beverages companies in the world with $300 million in net revenue, $20 million in adjusted EBITDA, $200 million in assets, and over $40 million in working capital.

For More Information On New Age Beverages Corporation, Click Here

CV Sciences, Inc (CVSI) announced, earlier this month, that it would be participating as a presenter at the BioTech Showcaseâ„¢ investor and networking conference in January 2019. Given that it will be the eleventh year the event has taken place the conference will provide attendees with opportunities to network with investors, sector analysts, and other industry professionals.

"Biotech Showcaseâ„¢ boasts a strong attendance of international investors, many of whom will be hearing our business model and investment opportunity for the first time," stated Chief Executive Officer Joseph Dowling. "The event is considered a critical early benchmark for investors in the new year that want to follow high growth opportunities in the small-cap biotech sector and we are excited to be utilizing this platform to communicate our recent strong quarterly growth announcement that included record sales, record gross profit and record GAAP Net Income."